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Background: Autonomic imbalance may play an important role in the pathogenesis of reversible cerebral
vasoconstriction syndromes (RCVS). This study aimed to assess the autonomic function by analyzing heart rate
variability (HRV) in patients with RCVS.
Methods: Patients with RCVS and age- and gender-matched controls were consecutively recruited. All patients
(both ictal and remission stage) and controls underwent 24-hour ambulatory electrocardiographic (ECG) recordings.
HRV measures covering time and frequency domains were used to assess autonomic functioning.
Results: Thirty-nine patients with RCVS and 39 controls completed the study. Compared to the controls, RCVS
patients during the ictal stage showed reductions in parasympathetic-related indices, including the root mean
square of difference of consecutive interbeat intervals (RMSSD) (22.1 ± 7.0 vs. 35.2 ± 14.2, p < 0.001), the percentage
of adjacent intervals that varied by more than 50 ms (pNN50) (3.7 ± 3.4 vs. 10.6 ± 8.1, p < 0.001), and high-frequency
power (HF) (5.82 ± 0.73 vs. 6.77 ± 0.74; p < 0.001), and increased low-frequency/high-frequency (LF/HF) ratio (index
of sympathovagal balance) (3.38 ± 1.32 vs. 2.48 ± 1.07; p =0.001). These HRV indices improved partially but remained
significantly different from controls during remission.
Conclusions: Decreased parasympathetic modulations and accentuated sympathetic activity might be a biological
trait in patients with RCVS.
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Reversible cerebral vasoconstriction syndrome (RCVS)
is a unifying term for a variety of clinical-radiological
syndromes characterized by recurrent thunderclap head-
aches and reversible multifocal cerebral vasoconstrictions
[1-4]. Many secondary causes have been identified [1,3,4];
however, in a substantial group of patients, RCVS occurs
spontaneously without any precipitating factors [2,3]. RCVS
is not uncommon and potentially devastating because of
high risks of complications such as posterior reversible
encephalopathy syndrome (PRES), ischemic stroke, in-
tracerebral hemorrhage (ICH) or cortical subarachnoid* Correspondence: sjwang@vghtpe.gov.tw
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in any medium, provided the original work is phemorrhage (SAH) [3,5-9]. The severity of vasoconstric-
tions is associated with PRES or ischemic stroke [6,7].
Despite gradual delineation of the clinical presenta-
tion, the underlying pathophysiology of RCVS remains
enigmatic. An aberrant central sympathetic response has
been proposed to play an important role [10], which can
be partly supported by the fact that RCVS can occur in
some patients with pheochromocytoma [11] and after
the use of sympathomimetics [12,13]. Besides, the obser-
vations of blood pressure surge and/or the Valsalva
maneuver-like triggers with elevated sympathetic tone
also heightened the role of autonomic dysregulation in
the pathogenesis [2]. However, to our knowledge no
study has directly investigated the roles of the auto-
nomic system in the pathogenesis of RCVS.
Analysis of heart rate variability (HRV), an established
method to study abnormalities of the autonomic func-
tion [14], is an appropriate and easily applicable methodOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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study employed standardized HRV measures to investi-
gate the autonomic function in patients with RCVS and
attempted to provide plausible pathophysiological mech-
anisms for this unique disorder.
Methods
Study subjects
We recruited consecutive patients presenting with acute
severe headaches from the headache clinic and emer-
gency department at Taipei Veterans General Hospital
(TVGH) from June 2006 to September 2010. Subjects
were excluded if they 1) were younger than 18 or older
than 65 years, 2) had severe cardiac arrhythmia, such as
continuous bigeminy, atrial fibrillation or atrial flutter, 3)
had diabetes mellitus, 4) had experienced a severe or
acute medical illness within 3 months preceding the
study, and 5) had been placed on medications with a
well-documented effect on HRV, such as tricyclic antide-
pressants with anti-cholinergic effects or beta blockers,
etc. [14]. Each subject completed a detailed headache
intake form and provided comprehensive medical and
headache histories before undergoing clinical and neuro-
logical examinations. Brain magnetic resonance imaging
(MRI), MR venography and MR angiography were per-
formed to exclude intracranial lesions attributable to the
patients’ headache. Spinal tap with cerebrospinal fluid
(CSF) analysis was performed to help diagnosis if
patients agreed. Subjects were hospitalized to expedite
completion of these diagnostic investigations if condition
allowed. If cerebral vasoconstrictions were demonstrated
on the initial MRA, sequential MRA was arranged to
evaluate their reversibility. Transcranial color-coded
Doppler sonography (TCCS) was performed on the same
day of the corresponding MRA. The methodology and
follow-up protocol of MRA and TCCS were detailed
elsewhere [6]. The participants were instructed to keep a
headache diary to optimize the diagnosis and treatment.
The diagnosis of RCVS required fulfillment of the
following criteria: (1) at least two acute-onset severe
headache (thunderclap headache), with or without focal
neurological deficits; (2) vasoconstrictions demonstrated
on magnetic resonance angiography (MRA); (3) revers-
ibility of vasoconstrictions, as demonstrated by at least
one follow-up MRA within 3 months; and (4) SAH or
other intracranial disorders ruled out by appropriate in-
vestigations, but cortical SAH in RCVS was allowed.
The diagnostic criteria were based on the definition of
“benign (or reversible) angiopathy of the central nervous
system” proposed by the International Classification of
Headache Disorders, second edition (ICHD-2) (Code
6.7.3) [15] and the essential diagnostic elements of RCVS
proposed by Calabrese et al. [1]. In addition, age- and
gender-matched controls were recruited from colleagues,their relatives, or a databank of controls of other auto-
nomic studies. Control subjects were eligible only when
they were devoid of any systemic diseases except for grade
1 hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
[16] and migraine. Hypertension and migraine were
allowed because they were not uncommon in patients
with RCVS. The study protocol was approved by the
TVGH Institutional Review Board. All patients signed
informed consent before entering the study.
Continuous electrocardiographic (ECG) monitoring
Subjects during the ictal stage received 24-hour ambula-
tory ECG monitoring using a Holter monitor (MyECG
E3-80 portable recorder, Microstar Inc., Taipei, Taiwan)
upon entering the study. This ECG study was defined as
ictal ECG. Headache abortive treatment with painkillers
was allowed during the 24-hour ECG monitoring if the
patients had headache attacks, but nimodipine treatment
was not implemented since a diagnosis of RCVS had not
been confirmed meanwhile. In order to prospectively
monitor the change of autonomic function in these pa-
tients, patients were asked to receive a follow-up ECG
monitoring when their RCVS remitted (i.e. vasoconstric-
tion had normalized and the patients had discontinued
nimodipine treatment for at least one month), which
was defined as a remission ECG. For the controls,
no follow-up ECG monitoring was implemented. The
Holter device continuously recorded three channels of
ECG signals at a sampling rate of 250 Hz. The digita-
lized ECG signals were then stored on the computer for
subsequent off-line HRV analysis by the custom software
according to the open source of HRV algorithms [17].
The HRV analysis was performed by the same investigator
(A.C.Y.) who was blind to clinical data.
Heart rate variability analysis
HRV measures covering time and frequency domains
were used in the analysis of R-R interval time series
according to international guidelines [14]. Time domain
HRV measures were derived for 24-hour time period,
including mean heart rate, the standard deviation of the
normal interbeat intervals (SDNN), the root mean
square of difference of consecutive interbeat intervals
(RMSSD), and the percentage of adjacent intervals that
varied by more than 50 ms (pNN50) [18]. The SDNN
assesses the overall variability of interbeat intervals. The
RMSSD and pNN50 measure the short-term variation of
interbeat intervals which is mainly modulated by the
parasympathetic activity [19].
Spectral HRV measures include high-frequency power
(HF; 0.15–0.40 Hz), low-frequency power (LF; 0.04–
0.15 Hz), very-low-frequency power (VLF; 0.003-0.04 Hz),
and LF/HF ratio. These spectral HRV indexes were aver-
aged from non-overlapping 30-minute segments for the
Table 1 The comparison of demographics, menopausal
status and current medical illness between patients with
RCVS and controls
Patients with RCVS Controls p value
(N = 39) (N = 39)
Mean age ± SD, years 49.5 ± 10.4 50.0 ± 4.7 0.56
Sex (M/F) 0/39 0/39 1.00
Hypertension, n (%) 3 (7.7) 3 (7.7) 1.00
Diabetes, n (%) 0 (0) 0 (0) 1.00
Migraine, n (%) 8 (20.5) 6 (15.3) 0.77
Menopause, n (%) 18 (46.2) 19 (48.7) 1.00
RCVS, Reversible cerebral vasoconstriction syndromes.
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30-minute segment of R-R interval were computed
by fast-Fourier transformation, with application of a
Hanning window to minimize spectral leakage. VLF
power is correlated with long-term fluctuations of inter-
beat intervals and is believed to be mediated partly by
the renin-angiotensin-aldosterone system [14]. LF power
has been reported to be modulated by both sympathetic
and parasympathetic activities, whereas the HF power is
mainly modulated by parasympathetic activity [20-22].
The LF/HF ratio represents the balance of autonomic sys-
tem and is thought to be an indicator of the sympathetic
activity [14,23].
Statistical analysis
Descriptive statistics were presented as means ± stand-
ard deviation or percentages and median with range for
non-normal distribution data. The spectral HRV indices
were log transformed to produce normalized distribu-
tions. Chi-square was used to compare the categorical
variables. Student’s t-test or paired t-test was used to de-
termine whether there were differences in HRV indices
between patients during ictal stage, remission stage, and
controls. For correlations between two continuous vari-
ables, Pearson correlation coefficient r was adopted. A
p value of less than 0.05 (two-tailed) was required for
statistical significance. Because these HRV variables were
highly correlated (14), corrections for multiple compari-
sons were not applied. All analyses were performed with
the IBM SPSS Statistics software package, version 18.0.
Results
Clinical characteristics
During the study period, we prospectively recruited 39
patients with RCVS who had both eligible ictal and
remission ECG monitoring. Thirty-nine subjects without
major medical and psychiatric disorders were recruited
as controls. The comparisons of demographics and asso-
ciated medical conditions between patients and controls
are listed in Table 1. The ictal ECG monitoring was
conducted at a median of 12.5 (range 3–45) days after
headache onset. The remission ECG monitoring was
performed at a median of 178 (range 43–247) days after
headache remission, at a time point that the MRA vaso-
constrictions of the participants had normalized for
107.5 (range 33–158) days.
Headaches in 79% of the patients with RCVS were
explosive at onset, 69% reported throbbing headache
after onset. Fifty-six percent reported nausea as an ac-
companying symptom, followed by phonophobia (38%),
photophobia (38%), and vomiting (36%). Triggers were
noted in 79% of study patients with the leading ones
being: Defecation (41%), exertion (31%), bathing (28%),
sex (26%), cough (18%) and rage (10%). The headachesremitted at a median of 14 (range 5–45) days. Three
patients developed PRES and one patient developed
acute ischemic stroke.
Parasympathetic-related HRV indices
The parasympathetic-related HRV indices including
RMSSD, pNN50, and HF power were significantly lower
in patients during the ictal stage compared with the con-
trols (Table 2). These indices improved partially during
the remission stage when compared with indexes during
the ictal stage (paired t-test), but remained lower than
those of controls (Table 2). In fact, an ascending trend
was observed in patients during the ictal stage, followed
by the remission stage and controls.
Sympathetic-related HRV index
The LF/HF ratios were significantly higher in patients
during the ictal stage compared with the controls based
on 24-hour HRV measures (Table 2). The consistent
finding was found when diurnal or nocturnal HRV was
compared between controls and patients during the ictal
stage. These higher LF/HF ratios partially normalized
during the remission stage (a nominal difference was
noted when compared with that of controls) (Table 2).
Other HRV indices
As the data in Table 2 demonstrated, patients during the
ictal stage had significant reductions in SDNN, the total
power and VLF, which were partially reversed but not
normalized when patients were in the remission stage.
The correlations of clinical variables and HRV indices
Because of small case number of patients with PRES
(n = 3) and ischemic stroke (n = 1) in our study partici-
pants, statistics were not conducted to correlate the HRV
indices with these complications. Nevertheless, patients
with PRES had nominally lower total power and VLF of
HRV (total power: 8.04 ± 0.58 vs. 8.52 ± 0.47; VLF: 7.83 ±
0.55 vs. 8.26 ± 0.46), lower parasympathetic indices
(RMSSD: 16.3 ± 6.4 vs. 22.5 ± 6.7; pNN50: 1.8 ± 2.0 vs.
Table 2 Comparison of heart rate variability profiles between patients with RCVS in ictal and remission stages
and controls
Controls RCVS patients (n = 39)
(n = 39) Ictal stage P value* Remission stage P value* P value**
Time domain variables
SDNN, ms 129.4 ± 34.7 109.9 ± 24.8 0.006 120.7 ± 24.9 0.207 0.041
RMSSD, ms 35.2 ± 14.2 22.1 ± 7.0 <0.001 26.7 ± 11.1 0.005 0.019
pNN 50,% 10.6 ± 8.1 3.7 ± 3.4 <0.001 5.6 ± 6.3 0.003 0.070
Frequency domain variables
Total power, ln (ms2/Hz) 9.01 ± 0.50 8.47 ± 0.48 <0.001 8.71 ± 0.40 0.005 0.008
VLF (0.003 – 0.04 Hz), ln (ms2/Hz) 8.66 ± 0.48 8.21 ± 0.46 <0.001 8.43 ± 0.37 0.017 0.011
LF (0.04 – 0.15 Hz), ln (ms2/Hz) 7.32 ± 0.60 6.63 ± 0.62 <0.001 6.90 ± 0.53 0.001 0.020
HF (0.15 – 0.4 Hz), ln (ms2/Hz) 6.77 ± 0.74 5.82 ± 0.73 <0.001 6.21 ± 0.75 0.001 0.016
LF/HF, ratio 2.48 ± 1.07 3.38 ± 1.32 0.001 2.97 ± 1.25 0.067 0.013
Values presented are mean ± SD.
*Comparison between patients and controls using Student’s t-test. ** Comparison between ictal and remission stage using paired-t test.
HF, High frequency power; LF, low frequency power; pNN50, Percentage of difference of successive interbeat intervals which are larger than 50 ms; RCVS,
Reversible cerebral vasoconstriction syndromes; RMSSD, The square root of the mean of the sum of the squares of differences between adjacent normal interbeat
intervals; SDNN, Standard deviation of normal inter-beat intervals; VLF, Very low frequency power.
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vated LF/HF ratio (4.13 ± 1.54 vs. 3.36 ± 1.25) than those
without PRES (n = 36). The other clinical variables such as
blood pressure surge, types and numbers of triggers, head-
ache duration, date of ECG performance from headache
onset (the ictal stage and the remission stage were calcu-
lated separately), history of hypertension or migraine, or
menopausal status did not correlate with any HRV indices.
Discussion
The study showed that patients with RCVS had mark-
edly decreased heart rate variability, attenuated para-
sympathetic modulations and heightened sympathetic
activity during the ictal stage. These autonomic aber-
rancies improved partially after disease remission, but
were still abnormal in comparison with that of controls.
These findings suggested that the autonomic dysfunction
is not simply an accompanying phenomenon during the
diseased stage but a biological trait marker in patients
with RCVS.
The proposed pathophysiology of RCVS has been
linked to sympathetic overactivity based on clinical
observations or hypotheses including central vascular
tone changes [8,24], aberrant sympathetic response [10],
blood pressure surge [5], triggers [3,5], sympathomimetic
agents [3,12,13], pheochromocytoma and hypertensive
crises [25], and autonomic dysreflexia [26], etc. Our
findings provided more direct evidence in support of
these speculations. A remarkably decreased parasympa-
thetic modulation was unexpected from clinical observa-
tions, but not irrational. Actually, the balance between
the sympathetic and parasympathetic systems is like the
balance of yin and yang [27]. For example, one armweakened could actually make the other arm unantago-
nized and prone to a diseased state. It is thus possible
that a dysfunctional autonomic nervous system renders
the individual more susceptible to thunderclap head-
aches by exaggeratedly reacting to certain triggers, espe-
cially Valsalva maneuver-like triggers, and at a lower
threshold. Cerebral blood vessels which were richly in-
nervated by sympathetic nerve fibers [28,29], might also
react to the heightened and unantagonized sympathetic
activities and exhibit features of multifocal vasoconstric-
tions. Although it is likely that the pathophysiology of
RCVS is multifactorial, we believe that central autonomic
dysregulation plays a crucial role based on the distinct
clinical presentations and the findings of this study.
It has been observed that during sympathetic activa-
tion the resulting tachycardia is usually accompanied by
a marked reduction in total power, which may influence
the change in HF and LF power in the same direction
and thus lead to a less prominent ratio of LF over HF
[14,30]. Hence, the higher LF/HF ratio observed in
patients was still underestimated by the presence of
decreased total power of HRV. Such sympathetic over-
activity exactly coincided with the previously proposed
neurogenic mechanism [10] and the foregoing deduc-
tion. Admittedly, one could speculate that an alternative
explanation may be that the sympathetic overactivity
was the consequence rather than the cause of severe
headaches since similar trends have been observed in
certain painful conditions [31-35]. However, such auto-
nomic dysfunction should normalize after removal of
the inciting factors. The persistently abnormal auto-
nomic modulation during the remission stage effectively
argues against this speculation.
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RCVS, this study avoided the influence of HRV from ex-
ogenous factors, such as sympathomimetic agents, thus
allowing us to examine the genuine endogenous auto-
nomic derangements in these patients. It is noteworthy
that low HRV measures are associated with onset and
poor prognosis of cardiovascular diseases [36,37]. Since
the case number of patients exhibiting PRES or ischemic
stroke is limited, we were unable to accredit the prog-
nostic value of HRV in predicting complications in
patients with RCVS although a trend of lower HRV in
found in patients with complications. However, given
that the extent of lower HRV was not as severe as those
with cardiovascular diseases, the prognosis of RCVS
might not be as grave using similar criteria [36,37].
Our study had limitations. First, naturally one cannot
study RCVS before it happens so that whether the ab-
normal cardiovascular autonomic responses in the RCVS
group are the result of the event or causal to it could
not be answered by the data. Second, HRV is highly
variable among individuals and can be affected by con-
founders such as age, gender, medical conditions includ-
ing hypertension [38] and migraine [35], as well as
menopausal status [39], etc. However, our study design
had attempted to exclude possible confounders by enrol-
ling matched controls and excluding subjects with
extreme ages and secondary RCVS. One study had
shown that migraineurs with disabling attacks may be
prone to hypofunction of autonomic nervous system,
but the causality between the autonomic hypofunction
and migraine was unknown [40]. It is possible that auto-
nomic dysfunction is a common finding in patients with
migraine or other severe headaches; however, the differ-
ence in study design and employed parameters made it
difficult to directly compare our findings with those of
previous studies. Whether there is difference in the
severity of autonomic dysfunction between RCVS and
migraine or other severe headaches requires further
sophisticatedly designed studies which also take disease
course into accounts. Of note, RCVS is known as a mono-
phasic disorder; whereas, it might be difficult to define a
true remission stage and the effects of therapeutics of pri-
mary headache disorders, such as migraine. Third, we are
uncertain whether the use of nimodipine in our patients
might have contributed to the changes in HRV during
follow-up since calcium channel blockers had been re-
ported to affect HRV [41,42]. To reduce the interference
from this effect, we structured this study to allow a wash-
out period from the use of the nimodipine. Finally, the
nature of our study method reflected the autonomic con-
trols on heart rates instead of directly on the control of
cerebral vascular tone. More exploratory studies are re-
quired to investigate the relationship between central
autonomic regulation and cerebral vasoconstrictions.Conclusion
Our study suggests that patients with RCVS have mark-
edly deranged autonomic function, namely decreased
heart rate variability, attenuated parasympathetic modu-
lations and heightened sympathetic activity in the ictal
stage. The autonomic derangement improved partially
during the remission stage but still deviated from those
of controls. The autonomic dysfunction might be a trait
rather than state in patients with RCVS, which makes
them more vulnerable to external triggers.
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